LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Jun 27, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-06-25

Reporting Person: VACZY CATHERINE M (VP and General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-25	Stock Option (Right to Buy)	$0.44	A	64583	Acquired	2022-06-24	Common Stock, par value $0.001 per share (64583)	Direct

Footnotes

F1: On June 25, 2012, the Compensation Committee of the Issuer's Board of Directors approved an arrangement whereby the Reporting Person was issued on June 25, 2012 an option (the "Option") to purchase that number of shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") equal to the Reporting Person's contactual salary increase scheduled to take effect on July 7, 2012 divided by $.36, the Black-Scholes value of such Option at the time of grant, under and subject to the Issuer's 2009 Equity Compensation Plan (the "Plan") and vesting ratably at the end of each month in which such salary increase is scheduled to be paid.